Advertisement

Topics

EF Johnson Technologies, Inc. Company Profile

02:43 EST 25th November 2017 | BioPortfolio

Headquartered in Irving, Texas, EF Johnson Technologies, Inc. focuses on innovating, developing and marketing the highest quality secure communications solutions to organizations whose mission is to protect and save lives. The Company's customers include first responders in public safety and public service, the federal government, and industrial organizations. The Company's products are marketed under the EFJohnson, 3e Technologies International, and Transcrypt International names and are Made in America. For more information, visit http://www.EFJohnsonTechnologies.com.


News Articles [864 Associated News Articles listed on BioPortfolio]

Johnson & Johnson Posting Notable Gain After Upgrade By Jefferies

NEW BRUNSWICK (dpa-AFX) - Shares of Johnson & Johnson (JNJ) have shown a notable move to the upside during trading on Wednesday, climbing by 2 percent. With the upward move, Johnson & Johnson has ...

Johnson & Johnson tops 2Q profit forecasts

This Tuesday, Sept. 13, 2016, file photo, shows Johnson & Johnson Band-Aid brand bandages in Surfside, Fla.

Johnson & Johnson: The Fundamentals of Alliance Management

Johnson & Johnson were one of the first companies to realise the importance of an alliance management group closely following in rival Eli Lilly & Co.’s footsteps. Rob Wills, VP Alliance Management ...

A Corporate Law Takeaway From Judge Nelson's Ruling In The Talcum Powder Case

After a three week trial that included extensive expert testimony, a Los Angeles jury returned a $417 million verdict against Johnson & Johnson and its subsidiary Johnson & Johnson Consumer, I...

Johnson & Johnson: Wait For The Drop Or Take The Shot?

This company tracks the S&P 500 index heavily, and thus waiting for a pullback may not be a feasible strategy in a bullish marketplace. Johnson & Johnson has undoubtedly had quite a good ride ...

4 Things That Matter When Johnson & Johnson Reports Its Second-Quarter Results

It's that time again, folks: Earnings season is kicking into full swing. And with that comes healthcare conglomerate Johnson & Johnson 's Johnson & Johnson is set to report its second-...

Johnson & Johnson Hit With $247M Verdict in Hip Implant Trial

A federal jury in Dallas on Thursday ordered Johnson & Johnson and its DePuy Orthopaedics unit to pay $247 million to six patients who said they were injured by defective Pinnacle hip implants. Reut...

Patient motivation platform debuted by J&J

The Johnson & Johnson Health Partner platform was launched by Johnson & Johnson for use in providing patients with personal m -More- 

PubMed Articles [394 Associated PubMed Articles listed on BioPortfolio]

Cefepime Associated With Phenytoin Induced Stevens-Johnson Syndrome.

We describe a recent case of Stevens-Johnson Syndrome. A 49-year-old man was admitted to the Intensive Care Unit of an Anaesthesia and Resuscitation Department because of a Fournier gangrene that deri...

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: Associations, Outcomes, and Pathobiology-Thirty Years of Progress but Still Much to Be Done.

Although rare, Stevens-Johnson syndrome and toxic epidermal necrolysis remain among the most devastating of acute conditions involving the skin. In the past 30 years, tremendous progress has been made...

Are steroids effective in toxic epidermal necrolysis and Stevens-Johnson syndrome?

Toxic epidermal necrolysis and Stevens-Johnson syndrome are severe adverse skin reactions to medications and infections. Steroids are described as a therapeutic alternative, but their use is still con...

Stevens-Johnson syndrome and toxic epidermal necrolysis: epidemiological and clinical outcomes analysis in public hospitals.

Adverse drug reactions are harmful and involuntary responses to drugs that occur at doses normally used for a given condition. Among them are Stevens-Johnson syndrome and toxic epidermal necrolysis, b...

Role of Scleral Contact Lenses in Management of Coexisting Keratoconus and Stevens-Johnson Syndrome.

To report the rare coexistence of keratoconus and Stevens-Johnson syndrome (SJS) managed with scleral contact lenses (ScCLs).

Clinical Trials [375 Associated Clinical Trials listed on BioPortfolio]

Stevens-Johnson Syndrome Antimicrobial

Steven-Johnson's syndrome, or great multiform erythema, appears as a systemic disturbance, with skin involvement and mucous membranes, related to several factors, such as, viral or bacteri...

Phase III Clinical Trial of NPB-01 in Patients With Stevens-Johnson Syndrome/ Toxic Epidermal Necrolysis Unresponsive to Corticosteroids.

Patients diagnosed with Stevens-Johnson syndrome and Toxic Epidermal Necrolysis were confirmed based on the investigators national diagnostic criteria. Patients who meet all inclusion crit...

Extracorporeal Photopheresis Pilot Study

ECP will be given to the patients [UVAR®XTS TM Therakos system, Johnson & Johnson] according to the following schedule: Starting at day 21 after transplant, if hematologic recovery allow...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fed Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

A Relative Bioavailability Study of 20 mg Famotidine Tablets Under Fasting Condition

The study was conducted as an open-label, balanced, randomized, two-treatment, two-period, two-sequence, single-dose, crossover, bioavailability study comparing famotidine tablets, USP 20 ...

Companies [1387 Associated Companies listed on BioPortfolio]

Johnson and Johnson

Johnson & Johnson, employing approximately 119,000 people worldwide, is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnso...

Johnson & Johnson Innovation

The London Innovation Centre is part of Johnson & Johnson Innovation, a division of Johnson & Johnson Finance Limited. Johnson & Johnson Innovation focuses on accelerating early i...

Johnson & Johnson (China) Investment Co., Ltd.

Johnson & Johnson (China) Investment Co., Ltd. is a foreign investment entity established in China by Johnson & Johnson in 1998. For more information about Johnson & Johnson and its operating unit...

JOHNSON'S(R) Brand

JOHNSON'S® Brand from Johnson & Johnson Consumer Products Company, Division of Johnson & Johnson Consumer Companies, Inc., has a long tradition of providing pure, mild, gentle and clinically-proven p...

JANSSEN-ORTHO INC

Since 1961 Janssen-Cilag has been a member of the Johnson & Johnson family of companies. Founded in 1886, Johnson & Johnson today is the world's most comprehensive manufacturer of healthcare products ...

More Information about "EF Johnson Technologies, Inc." on BioPortfolio

We have published hundreds of EF Johnson Technologies, Inc. news stories on BioPortfolio along with dozens of EF Johnson Technologies, Inc. Clinical Trials and PubMed Articles about EF Johnson Technologies, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of EF Johnson Technologies, Inc. Companies in our database. You can also find out about relevant EF Johnson Technologies, Inc. Drugs and Medications on this site too.

Quick Search
Advertisement
 

Corporate Database Quicklinks



Searches Linking to this Company Record